Magyar cégek hozhatnak áttörést az Alzheimer-kór elleni küzdelemben
2018.01.19
Szakmai és üzleti szempontból is kiemelkedő eredményt hozott a gyógyszerfejlesztés területén dolgozó SONEAS Kutató Kft. és AVIDIN Kft együttműködése. Az AVIDIN Kft. 2009-től foglalkozik Alzheimer-kór elleni gyógyszerkutatással. A cég molekuláris szintű biológiai és kémiai fejlesztései során fedezte fel azt az originális gyógyszerjelöltet (Q134R-K), amelyet a projektben résztvevő partnereivel ,,Kinolol” néven szabadalmaztatott világszerte. A készítmény Fázis […]
Tájékoztató cégnév módosításáról
2015.10.07
Ezúton szeretnénk tájékoztatni Önöket, hogy a Ubichem Kutató Kft. cégneve SONEAS Kutató Kft-re (angolul: SONEAS Research Ltd.) változott, A névváltással kapcsolatos tájékoztató megtekintése (pdf). valamint, hogy a Ubichem Pharma Manufacturing Kft. cégneve SONEAS Vegyipari Kft-re (angolul: SONEAS Chemicals Ltd.) változott. A névváltással kapcsolatos tájékoztató megtekintése (pdf).
UBICHEM Pharma Group inks deal to produce XiMo’s metathesis catalysts
2014.09.01
UBICHEM Pharma Group has entered into a strategic partnership with Swiss-based XiMo AG, a company focusing on the development and application of proprietary metathesis catalysts, for use in the specialty chemical, agro chemical, renewables, pharmaceutical, flavors and fragrances, polymers and advanced materials sectors. “Our molybdenum and tungsten catalysts are based on the breakthrough scientific research of […]
UBICHEM Pharma Group adds new large scale manufacturing site
Today UBICHEM Pharma Group announced further growth of its business by adding a new manufacturing site. The new member of the group, UBICHEM Pharma Manufacturing, will be producing starting materials, intermediates and other fine chemical products for pharma and non-pharma applications in industrial quantities. This expansion positions the UBICHEM Pharma Group to be one of […]
Small is beautiful – changing paradigm in the drug discovery
2012.03.12
The Global Discovery to Development Innovations Forum was held in Budapest on 7-9 March 2012 in partnership with Ubichem Pharma Services. Mr. József Répási, CEO, Ubichem Pharma Services presented the new ways in drug discovery and development.
Ubichem Research acquisition
2011.05.30
Ubichem Research acquisition to enable further growth of Pharma Services business The majority share of Ubichem Research Ltd has been acquired by financial investment company Lochlomond Holding Limited, owned by Marton Szoke, and is now independent of Ubichem Plc in the UK. The remaining minority share of Ubichem Research remains in the ownership of Mr. […]
Discovery Chemical Catalogue website
2010.10.10
Ubichem Pharma Services, a leading provider of chemistry services to the drug development sector, has recently launched a new website to house its expanded Discovery Chemical Catalogue. It can be accessed directly at www.ubichemdirect.com or from the Ubichem Pharma Services website at www.ubichempharma.com, allowing you to search the functionalised building blocks and purchase compounds which […]
cGMP radiolabelled API production
2010.10.09
Ubichem is pleased to announce that its Hungarian operation – Ubichem Research – has successfully completed a regulatory inspection and is now approved for the supply of cGMP radiolabelled Active Pharmaceutical Ingredients (APIs). Jozsef Repasi, Managing Director of Ubichem Research commented: “This approval enables us to supply radiolabelled materials for use in human clinical […]